Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of products that address significant unmet needs in Central Nervous System (CNS) disorders and other rare disorders. The company was founded by Raj Mehra in 1987 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Seelos Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Seelos Therapeutics Inc market cap is $0.00.
What is the 52-week high for Seelos Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Seelos Therapeutics Inc 52 week high is $1.34 as of September 16, 2025.
What is the 52-week low for Seelos Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Seelos Therapeutics Inc 52 week low is $0.00 as of September 16, 2025.
What is the PE ratio of Seelos Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Seelos Therapeutics Inc’s P/E ratio is 0.00.
What is the Price-to-Book ratio of Seelos Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Seelos Therapeutics Inc P/B ratio is 0.0000.
What is the 50-day moving average of Seelos Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Seelos Therapeutics Inc 50-day moving average is $0.00.
SEEL Seelos Therapeutics Inc